Australia markets close in 4 hours 45 minutes

Calliditas Therapeutics AB (publ) (CALT)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
22.42+0.66 (+3.03%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in SEK. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-524,820
-466,185
-412,268
-500,293
-433,494
-
Depreciation & amortisation
-
48,726
12,913
34,433
2,823
-
Stock-based compensation
-
52,591
35,791
21,960
6,012
-
Change in working capital
-3,899
-79,741
88,420
5,470
54,083
-
Inventory
-
-16,781
-2,758
-949
0
-
Other working capital
-413,708
-447,443
-313,866
-484,242
-309,181
-
Other non-cash items
-30,607
-19,725
15,902
4,428
-4
-
Net cash provided by operating activities
-400,920
-434,655
-311,354
-461,588
-309,181
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-12,788
-2,512
-22,654
-
-16,184
Acquisitions, net
-
-
0
0
-172,602
0
Purchases of investments
-
-1,560
-2,633
-1,686
-5
-
Sales/maturities of investments
-
602
0
0
-
-
Other investing activities
-
1
1
-24,340
-172,607
-
Net cash used for investing activities
-14,690
-13,745
-5,144
-24,340
-172,607
-
Cash flows from financing activities
Debt repayment
-739,111
-736,613
-9,615
-5,575
-3,972
-
Common stock issued
-
0
236
324,000
891,388
-
Common stock repurchased
-
0
-236
0
0
-
Other financing activities
-
-26,626
-1,261
-82,787
-178,109
-
Net cash used provided by (used for) financing activities
197,153
199,651
575,991
435,161
768,558
-
Net change in cash
-218,458
-248,750
259,493
-50,766
286,770
-
Cash at beginning of period
1,013,600
1,249,094
955,507
996,304
753,540
-
Cash at end of period
795,141
973,733
1,249,094
955,507
996,304
-
Free cash flow
Operating cash flow
-400,920
-434,655
-311,354
-461,588
-309,181
-
Capital expenditure
-
-12,788
-2,512
-22,654
-
-16,184
Free cash flow
-413,708
-447,443
-313,866
-484,242
-309,181
-